Single nef proteins from HIV type 1 subtypes C and F fail to upregulate invariant chain cell surface expression but are active for other functions

AIDS Research and Human Retroviruses

Volumn 25, Issue 3, 2009, Pages 285-296

  Turk, Gabriela ^a   Gundlach, Swantje ^b   Carobene, Mauricio ^a   Schindler, Michael ^b   Salomon, Horacio ^a   Benaroch, Philippe ^c,d  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^c INSTITUT CURIE   (France)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN II; CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE ANTIGEN; NEF PROTEIN; UNCLASSIFIED DRUG; B LYMPHOCYTE ANTIGEN; HLA ANTIGEN CLASS 2; IMMUNOGLOBULIN RECEPTOR; NEF PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1;

ALLELE; ARTICLE; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; GENE IDENTIFICATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LEUKEMIA CELL LINE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; UPREGULATION; VIRUS STRAIN; AMINO ACID SEQUENCE; BIOSYNTHESIS; CELL CULTURE; CLASSIFICATION; GENE EXPRESSION REGULATION; GENETICS; GENOTYPE; HELA CELL; IMMUNOLOGY; INVARIANT CHAIN; MOLECULAR GENETICS; MONONUCLEAR CELL; PHYLOGENY; PHYSIOLOGY; SEQUENCE ALIGNMENT; VIROLOGY;

AMINO ACID SEQUENCE; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; CELLS, CULTURED; GENE EXPRESSION REGULATION; GENOTYPE; HELA CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HIV-1; HUMANS; JURKAT CELLS; LEUKOCYTES, MONONUCLEAR; MOLECULAR SEQUENCE DATA; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; PHYLOGENY; RECEPTORS, IMMUNOLOGIC; SEQUENCE ALIGNMENT;

EID: 65449123927     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2008.0132     Document Type: Article

References (38)

1. Simon V, Ho DD, and Abdool Karim Q: HIV/AIDS epidemiology, pathogenesis, prevention, and treatment. Lancet 2006;368(9534):489-504.
2. Butler IF, Pandrea I, Marx PA, and Apetrei C: HIV genetic diversity: Biological and public health consequences. Curr HIV Res 2007;5:23-45.
3. Dilernia D, Gomez A, Lourtau L, Marone R, Losso M, Salomon H, and Gomez-Carrillo M: HIV-1 genetic diversity surveillance among newly diagnosed individuals in Buenos Aires, Argentina. AIDS Res Hum Retroviruses 2007;23(10): 1201-1207.
4. Turk G, Carobene M, Monczor A, Rubio AE, Gomez-Carrillo M, and Salomon H: Higher transactivation activity associated with LTR and Tat elements from HIV-1 BF intersubtype recombinant variants. Retrovirology 2006;3:14.
5. Turk G, Gherardi MM, Laufer N, Saracco M, Luzzi R, Cox JH, Cahn P, and Salomon H: Magnitude, breadth, and functional profile of T-cell responses during human immu- nodeficiency virus primary infection with B and BF viral variants. J Virol 2008;82(6):2853-2866.
6. Anderson S, Shugars DC, Swanstrom R, and Garcia JV: Nef from primary isolates of human immunodeficiency virus type 1 suppresses surface CD4 expression in human and mouse cells. J Virol 1993;67(8):4923-4931.
7. Mariani R and Skowronski J: CD4 down-regulation by nef alleles isolated from human immunodeficiency virus type 1-infected individuals. Proc Natl Acad Sci USA 1993;90(12): 5549-5553.
8. Schwartz O, Marechal V, Le Gall S, Lemonnier F, and Heard JM: Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat Med 1996;2(3):338-342.
9. Schindler M, Wurfl S, Benaroch P, Greenough TC, Daniels R, Easterbrook P, Brenner M, Munch J, and Kirchhoff F: Down-modulation of mature histocompatibility complex class IIand up-regulation of invariant chain cell surface expression are well-conserved functions of human and simian immunodeficiency virus nef alleles. J Virol 2003;77(19):10548-10556.
10. Stumptner-Cuvelette P, Morchoisne S, Dugast M, Le Gall S, Raposo G, Schwartz O, and Benaroch P: HIV-1 Nef impairs MHC class II antigen presentation and surface expression. Proc Natl Acad Sci USA 2001;98(21):12144-12149.
11. Arold ST and Baur AS: Dynamic Nef and Nef dynamics: How structure could explain the complex activities of this small HIV protein. Trends Biochem Sci 2001;26(6):356-363.
12. Joseph AM, Kumar M, and Mitra D: Nef: "necessary and enforcing factor" in HIV infection. Curr HIV Res 2005;3:87-94.
13. Roeth JF and Collins KL: Human immunodeficiency virus type 1 Nef: Adapting to intracellular trafficking pathways. Microbiol Mol Biol Rev 2006;70(2):548-563.
14. Allen TM, Altfeld M, Geer SC, Kalife ET, Moore C, O'Sullivan KM, Desouza I, Feeney ME, Eldridge RL, Maier EL, Kaufmann DE, Lahaie MP, Reyor L, Tanzi G, Johnston MN, Brander C, Draenert R, Rockstroh JK, Jessen H, Rosenberg ES, Mallal SA, and Walker BD: Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution. J Virol 2005; 79(21):13239-13249.
15. Leslie AJ, Pfafferott KJ, Chetty P, Draenert R, Addo MM, Feeney M, Tang Y, Holmes EC, Allen T, Prado JG, Altfeld M, Brander C, Dixon C, Ramduth D, Jeena P, Thomas SA, St John A, Roach TA, Kupfer B, Luzzi G, Edwards A, Taylor G, Lyall., Tudor-Williams G, Novelli V, Martinez-Picado J, Kiepiela P, Walker BD, and Goulder PJ: HIV evolution: CTL escape mutation and reversion after transmission. Nat Med 2004;10(3):282-289.
16. Lichterfeld M, Yu XG, Cohen D, Addo MM, Malenfant J, Perkins B, Pae E, Johnston MN, Strick D, Allen TM, Rosenberg ES, Korber B, Walker BD, and Altfeld M: HIV-1 Nef is preferentially recognized by CD8 T cells in primary HIV-1 infection despite a relatively high degree of genetic diversity. AIDS 2004;18(10):1383-1392.
17. Jubier-Maurin V, Saragosti S, Perret J, Mpoudi E, Esu-Williams E, Mulanga C, Liegeois F, Ekwalanga M, Delaporte E, and Peeters M: Genetic characterization of the nef gene from human immunodeficiency virus type I group M strains representing genetic subtypes A, B, C, E, F, G, and H. AIDS Res Hum Retroviruses 1999;15(1):23-32.
18. Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, Rabson A, and Martin MA: Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 1986;59(2):284-291.
19. Carr JK, Avila M, Gomez Carrillo M, Salomon H, Hierholzer J, Watanaveeradej V, Pando MA, Negrete M, Russell KL, Sanchez J, Birx DL, Andrade R, Vinoles J, and McCutchan FE: Diverse BF recombinants have spread widely since the introduction of HIV-1 into South America. AIDS 2001;15(15): F41-47.
20. Gao F, Robertson DL, Carruthers CD, Morrison SG, Jian B, Chen Y, Barre-Sinoussi F, Girard M, Srinivasan A, Abimiku AG, Shaw GM, Sharp PM, and Hahn BH: A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1. J Virol 1998;72(7):5680-5698.
21. Lock M, Greenberg ME, Iafrate AJ, Swigut T, Muench J, Kirchhoff F, Shohdy N, and Skowronski J: Two elements target SIV Nef to the AP-2 clathrin adaptor complex, but only one is required for the induction of CD4 endocytosis. EMBO J 1999;18(10):2722-2733.
22. Schindler M, Munch J, Kutsch O, Li H, Santiago ML, Bibollet-Ruche F, Muller-Trutwin MC, Novembre FJ, Peeters M, Courgnaud V, Bailes E, Roques P, Sodora DL, Silvestri G, Sharp PM, Hahn BH, and Kirchhoff F: Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell 2006;125(6):1055-1067.
23. Schindler M, Wildum S, Casartelli N, Doria M, and Kirchhoff F: Nef alleles from children with non-progressive HIV-1 infection modulate MHC-II expression more efficiently than those from rapid progressors. AIDS 2007;21(9): 1103-1107.
24. Benaroch P, Yilla M, Raposo G, Ito K, Miwa K, Geuze HJ, and Ploegh HL: How MHC class II molecules reach the endocytic pathway. EMBO J 1995;14(1):37-49.
25. Craig HM, Pandori MW, and Guatelli JC: Interaction of HIV-1 Nef with the cellular dileucine-based sorting pathway is required for CD4 down-regulation and optimal viral infectivity. Proc Natl Acad Sci USA 1998;95(19):11229-11234.
26. Stumptner-Cuvelette P, Jouve M, Helft J, Dugast M, Glouzman AS, Jooss K, Raposo G, and Benaroch P: Human immunodeficiency virus-1 Nef expression induces intracellular accumulation of multivesicular bodies and major histocompatibility complex class II complexes: Potential role of phosphatidylinositol 3-kinase. Mol Biol Cell 2003;14(12), 4857-4870.
27. Toussaint H, Gobert FX, Schindler M, Banning C, Kozik P, Jouve M, Kirchhoff F, and Benaroch P: Human immunodeficiency virus type 1 nef expression prevents AP-2-mediated internalization of the major histocompatibility complex class II-associated invariant chain. J Virol 2008;82(17):8373-8382.
28. Johannes L, Pezo V, Mallard F, Tenza D, Wiltz A, Saint-Pol A, Helft J, Antony C, and Benaroch P: Effects of HIV-1 Nef on retrograde transport from the plasma membrane to the endoplasmic reticulum. Traffic 2003;4(5):323-332.
29. Arien KK, Vanham G, and Arts EJ: Is HIV-1 evolving to a less virulent form in humans? Nat Rev Microbiol 2007;5(2): 141-151.
30. Ramírez de Arellano E, Soriano V, Alcami J, and Holguín A: New findings on transcription regulation across different HIV-1 subtypes. AIDS Rev 2006;8:9-16.
31. Mangasarian A, Piguet V, Wang JK, Chen YL, and Trono D: Nef-induced CD4 and major histocompatibility complex class I (MHC-I) down-regulation are governed by distinct determinants: N-terminal alpha helix and proline repeat of Nef selectively regulate MHC-I trafficking. J Virol 1999;73(3): 1964-1973.
32. Lubben NB, Sahlender DA, Motley AM, Lehner PJ, Benaroch P, and Robinson MS: HIV-1 Nef-induced down-regulation of MHC class I requires AP-1 and clathrin but not PACS-1 and is impeded by AP-2. Mol Biol Cell 2007;18(9):3351-3365.
33. Williams M, Roeth JF, Kasper MR, Filzen TM, and Collins KL: Human immunodeficiency virus type 1 Nef domains required for disruption of major histocompatibility complex class I trafficking are also necessary for coprecipitation of Nef with HLA-A2. J Virol 2005;79(1):632-636.
34. Carl S, Greenough TC, Krumbiegel M, Greenberg M, Skowronski J, Sullivan JL, and Kirchhoff F: Modulation of different human immunodeficiency virus type 1 Nef functions during progression to AIDS. J Virol 2001;75(8):3657-3665.
35. Stumptner-Cuvelette P and Benaroch P: Multiple roles of the invariant chain in MHC class II function. Biochim Biophys Acta 2002;1542(1-3):1-13.
36. Keppler OT, Tibroni N, Venzke S, Rauch S, and Fackler OT: Modulation of specific surface receptors and activation sensitization in primary resting CD4+ T lymphocytes by the Nef protein of HIV-1. J Leukoc Biol 2006;79(3):616-627.
37. Dugast M, Toussaint H, Dousset C, and Benaroch P: AP2 clathrin adaptor complex, but not AP1, controls the access of the major histocompatibility complex (MHC) class II to endosomes. J Biol Chem 2005;280(20):19656-19664.
38. Mitchell RS, Chaudhuri R, Lindwasser OW, Tanaka KA, Lau D, Murillo R, Bonifacino JS, and Guatelli JC: Competition model for upregulation of the major histocompatibility complex class II-associated invariant chain by human immunodeficiency virus type 1 Nef. J Virol 2008;82(16):7758-7767.